Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.

Saved in:
Bibliographic Details
Title: Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.
Authors: Samaraweera SE; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., Geukens T; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Department of Oncology, KU Leuven, Leuven, Belgium., Casolari DA; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., Nguyen T; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., Sun C; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia., Bailey S; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia; Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Moore S; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia., Feng J; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; ACRF Cancer Genomics Facility, SA Pathology, Adelaide, SA, Australia., Schreiber AW; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia; ACRF Cancer Genomics Facility, SA Pathology, Adelaide, SA, Australia; School of Biological Sciences, The University of Adelaide, Adelaide, SA, Australia., Parker WT; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia., Brown AL; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia., Butcher C; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia., Bardy PG; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia., Osborn M; South Australia/Northern Territory Youth Cancer Service, Royal Adelaide Hospital, Adelaide, SA, Australia; Department of Haematology and Oncology, Women's and Children's Hospital, North Adelaide, SA, Australia., Scott HS; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; ACRF Cancer Genomics Facility, SA Pathology, Adelaide, SA, Australia., Talaulikar D; Haematology Translational Research Unit, ACT Pathology, Canberra Hospital, Canberra, ACT, Australia., Grove CS; Department of Haematology, Sir Charles Gairdner Hospital and PathWest, Perth, WA, Australia., Hahn CN; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia., D'Andrea RJ; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., Ross DM; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; Department of Haematology and Genetic Pathology, Flinders University and Medical Centre, Bedford Park, SA, Australia. Electronic address: david.ross@sa.gov.au.
Source: Pathology [Pathology] 2023 Feb; Vol. 55 (1), pp. 77-85. Date of Electronic Publication: 2022 Aug 05.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1465-3931
DOI:10.1016/j.pathol.2022.05.015